Replimune Group, Inc. (REPL)
8.465
-0.78
(-8.39%)
USD |
NASDAQ |
Jun 10, 16:00
8.505
+0.04
(+0.47%)
After-Hours: 20:00
Replimune Group SG&A Expense (Quarterly) : 18.73M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 18.73M |
| September 30, 2025 | 26.41M |
| June 30, 2025 | 32.58M |
| March 31, 2025 | 25.35M |
| December 31, 2024 | 18.02M |
| September 30, 2024 | 15.47M |
| June 30, 2024 | 14.40M |
| March 31, 2024 | 16.18M |
| December 31, 2023 | 13.69M |
| September 30, 2023 | 14.73M |
| June 30, 2023 | 15.21M |
| March 31, 2023 | 15.04M |
| December 31, 2022 | 11.37M |
| September 30, 2022 | 12.74M |
| June 30, 2022 | 11.40M |
| March 31, 2022 | 10.25M |
| December 31, 2021 | 10.34M |
| September 30, 2021 | 9.345M |
| Date | Value |
|---|---|
| June 30, 2021 | 8.827M |
| March 31, 2021 | 5.959M |
| December 31, 2020 | 5.953M |
| September 30, 2020 | 5.613M |
| June 30, 2020 | 5.676M |
| March 31, 2020 | 5.197M |
| December 31, 2019 | 4.716M |
| September 30, 2019 | 4.074M |
| June 30, 2019 | 3.45M |
| March 31, 2019 | 2.413M |
| December 31, 2018 | 2.28M |
| September 30, 2018 | 2.142M |
| June 30, 2018 | 1.943M |
| March 31, 2018 | 2.562M |
| December 31, 2017 | 1.159M |
| September 30, 2017 | 1.107M |
| June 30, 2017 | 0.885M |
| March 31, 2017 | 1.236M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 101.25M |
| Oncolytics Biotech, Inc. | 4.729M |
| Rocket Pharmaceuticals, Inc. | 17.06M |
| Cogent Biosciences, Inc. | 28.24M |
| Lantern Pharma, Inc. | 1.680M |